253 related articles for article (PubMed ID: 21809988)
1. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.
Busam KJ; Tan LK; Granter SR; Kohler S; Junkins-Hopkins J; Berwick M; Rosen PP
Mod Pathol; 1999 Aug; 12(8):786-93. PubMed ID: 10463481
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
Mentrikoski MJ; Wick MR
Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma.
Fernandez-Flores A
Rom J Morphol Embryol; 2012; 53(4):879-92. PubMed ID: 23303010
[TBL] [Abstract][Full Text] [Related]
7. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
8. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
Chia SY; Thike AA; Cheok PY; Tan PH
Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.
Levy G; Finkelstein A; McNiff JM
J Cutan Pathol; 2010 Apr; 37(4):411-5. PubMed ID: 19788442
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
[TBL] [Abstract][Full Text] [Related]
12. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
Bayer-Garner IB; Smoller B
Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin profiles of male breast cancers.
Ciocca V; Bombonati A; Gatalica Z; Di Pasquale M; Milos A; Ruiz-Orrico A; Dreher D; Folch N; Monzon F; Santeusanio G; Perou CM; Bernard PS; Palazzo JP
Histopathology; 2006 Oct; 49(4):365-70. PubMed ID: 16978199
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.
Sariya D; Ruth K; Adams-McDonnell R; Cusack C; Xu X; Elenitsas R; Seykora J; Pasha T; Zhang P; Baldassano M; Lessin SR; Wu H
Arch Dermatol; 2007 May; 143(5):613-20. PubMed ID: 17515511
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
[TBL] [Abstract][Full Text] [Related]
17. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.
Luo MH; Huang YH; Ni YB; Tsang JY; Chan SK; Shao MM; Tse GM
Hum Pathol; 2013 Jul; 44(7):1241-50. PubMed ID: 23332923
[TBL] [Abstract][Full Text] [Related]
18. Topics in histopathology of sweat gland and sebaceous neoplasms.
Ansai SI
J Dermatol; 2017 Mar; 44(3):315-326. PubMed ID: 28256768
[TBL] [Abstract][Full Text] [Related]
19. Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma.
Fernandez-Flores A
Cesk Patol; 2009 Oct; 45(4):108-12. PubMed ID: 20301838
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
Cangelosi JJ; Nash JW; Prieto VG; Ivan D
Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
